- Home
- AARD vs OM Comparison
AARD vs OM Comparison
Compare AARD & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- OM
- Stock Information
- Founded
- AARD 2017
- OM 2003
- Country
- AARD United States
- OM United States
- Employees
- AARD N/A
- OM N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AARD Health Care
- OM Health Care
- Exchange
- AARD Nasdaq
- OM Nasdaq
- Market Cap
- AARD 277.9M
- OM 224.0M
- IPO Year
- AARD 2025
- OM 2020
- Fundamental
- Price
- AARD $11.22
- OM $14.75
- Analyst Decision
- AARD Strong Buy
- OM Hold
- Analyst Count
- AARD 7
- OM 1
- Target Price
- AARD $31.43
- OM $22.00
- AVG Volume (30 Days)
- AARD 151.9K
- OM 312.0K
- Earning Date
- AARD 11-14-2025
- OM 11-10-2025
- Dividend Yield
- AARD N/A
- OM N/A
- EPS Growth
- AARD N/A
- OM N/A
- EPS
- AARD N/A
- OM N/A
- Revenue
- AARD N/A
- OM $119,304,000.00
- Revenue This Year
- AARD N/A
- OM $12.46
- Revenue Next Year
- AARD N/A
- OM $10.51
- P/E Ratio
- AARD N/A
- OM N/A
- Revenue Growth
- AARD N/A
- OM 2.47
- 52 Week Low
- AARD $4.88
- OM $5.85
- 52 Week High
- AARD $19.58
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- AARD 39.08
- OM 52.68
- Support Level
- AARD $10.65
- OM $14.74
- Resistance Level
- AARD $17.94
- OM $15.94
- Average True Range (ATR)
- AARD 0.95
- OM 1.15
- MACD
- AARD -0.64
- OM 0.11
- Stochastic Oscillator
- AARD 7.82
- OM 68.96
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.